Search Results 231-240 of 21219 for Inhibition

1. Perindopril and amlodipine (oral route) - Side effects & dosage - Mayo Clinic

   Lowering blood pressure can reduce the risk of strokes and heart attacks. Perindopril is an angiotensin-converting enzyme (ACE) inhibitor. It works by blocking ...

2. Selegiline (transdermal route) - Mayo Clinic

   Selegiline skin patch is used to treat mental depression in adults. This medicine is a monoamine oxidase inhibitor (MAOI). This medicine is available only with ...

3. Anastasia Zekeridou, M.D., Ph.D. - Mayo Clinic Faculty Profiles

   Neurological complications of immune-checkpoint inhibitor cancer immunotherapy. Dr. Zekeridou studies pathophysiology, clinical presentation, treatment and ...

4. Evaluation of the AMICUS Extracorporeal Photopheresis (ECP) System in Patients with Chronic Graft Versus Host Disease - Mayo Clinic

   The purpose of this study is to evaluate the inhibition of lymphocyte proliferation in ECP treated MNC samples obtained from cGVHD subjects treated with the ...

5. Researchers seek to increase use of sirolimus-based immunosuppression for heart transplant recipients - Mayo Clinic

   Drew N. Rosenbaum, M.D., a Mayo Clinic transplant cardiologist, discusses optimal conversion time from calcineurin inhibitor to sirolimus immunosuppression ...

6. Ezetimibe (oral route) - Side effects & dosage - Mayo Clinic

   Ezetimibe is a cholesterol absorption inhibitor. This medicine will reduce the absorption of cholesterol from foods and the production of cholesterol in ...

7. Novel proton therapy technique shows promise with resistant cancer cells - Mayo Clinic

   Mutter says a surprising finding was that ATM inhibition could uniquely enhance the effectiveness of LEAP , but not inhibitors of other DNA double-strand ...

8. GLP-1RA and thyroid cancer: New study suggests detection bias, not causation - Mayo Clinic

   ... inhibitors, DPP-4 inhibitors or sulfonylureas, minimizing the potential for confounding that has plagued previous research. The primary finding offers ...

9. A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis Patients Who Are Naive to TNF Inhibitors - Mayo Clinic

   A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis Patients Who Are Naive to TNF Inhibitors.

10. Ribociclib and letrozole (oral route) - Side effects & dosage - Mayo Clinic

    ... inhibitor as the first endocrine-based treatment. Ribociclib belongs to the group of medicines called antineoplastics. It interferes with the growth of ...